U.S.: Investigation opened into Vascular’s illegal marketing of medical device
Consumer protection firm Faruqi & Faruqi, LLP, have opened an investigation into the alleged wrongdoing at Vascular Solutions Inc. over whether the company mis-sold its Vari-Lase medical device for unapproved uses. Vascular announced they had received a subpoena in June of 2011 for documentation related to the company’s products, specifically of the Vari-Lase Short Kid, used for the treatment of perforator veins. Complaints filed last August claim Vascular paid doctors illegal kickbacks to increase sales of the device for non-approved uses.
Full Content: The Sacramento Bee
Related Content: EU exec raids suspected French biomedical cartel
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Japan’s Nippon Steel Eyes Year-End Close on $15B US Steel Deal Amid Political Uncertainty
Nov 7, 2024 by
CPI
Canada Orders Dissolution of TikTok’s Business Amid National Security Concerns
Nov 7, 2024 by
CPI
India Raids Amazon, Flipkart Seller Offices in Foreign Investment Probe
Nov 7, 2024 by
CPI
Canada’s Competition Bureau Seeks Public Feedback on Updated Merger Guidelines
Nov 7, 2024 by
CPI
FTC Adopts Stricter Reporting Rules for Mergers, Delays Expected in 2025
Nov 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI